Logo

American Heart Association

  35
  0


Final ID:

Obtaining access to cardioprotective anti-hyperglycemic therapies to promote CKM health

  • Joseph, Joshua  ( The Ohio State University COM , Columbus , Ohio , United States )
  • Modarressi, Taher  ( Princeton Cardiometabolic Health , Pennington , New Jersey , United States )
  • Author Disclosures:
    Joshua Joseph: DO NOT have relevant financial relationships | Taher Modarressi: DO have relevant financial relationships ; Advisor:Novo Nordisk:Active (exists now) ; Speaker:AstraZeneca:Past (completed) ; Speaker:Madrigal Pharmaceuticals:Active (exists now) ; Speaker:Abbott:Active (exists now) ; Speaker:Amgen:Active (exists now) ; Speaker:Eli Lilly:Active (exists now) ; Research Funding (PI or named investigator):Eli Lilly:Active (exists now) ; Research Funding (PI or named investigator):Amgen:Active (exists now) ; Research Funding (PI or named investigator):AstraZeneca:Active (exists now) ; Consultant:CRISPR Therapeutics:Past (completed) ; Consultant:Novo Nordisk:Active (exists now) ; Advisor:Eli Lilly:Active (exists now) ; Advisor:Regeneron:Active (exists now) ; Advisor:New Amsterdam:Active (exists now) ; Advisor:Novartis:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Optimizing CKM Health in Primary Care

Sunday, 11/09/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
More abstracts from these authors:
Discuss Case Study 1 in Breakout Groups

Joseph Joshua, Khan Sadiya, Ndumele Chiadi, Lala-trindade Anuradha, Vest Amanda, Vardeny Orly, Powell-wiley Tiffany, Modarressi Taher, Pagidipati Neha, Magwire Melissa, Rangaswami Janani

The AHA CKM Health Initiative : The Future of Holistic Care

Ndumele Chiadi, Joseph Joshua

You have to be authorized to contact abstract author. Please, Login
Not Available